COM:ALDEYRA
Aldeyra Therapeutics, Inc.
- Stock
5.75
−13.79%
3.86
Last Close
1.89
10/04 22:28
Market Cap
343.32M
Beta: -
Volume Today
2.96M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -5.19M - | -12.09M 133.08% | -18.70M 54.67% | -22.34M 19.47% | -38.89M 74.09% | -60.83M 56.39% | -37.55M 38.26% | -57.78M 53.85% | -62.02M 7.35% | -37.54M 39.47% | |
depreciation and amortization | 1.07K - | 18.78K 1,656.59% | 35.79K 90.61% | 37.85K 5.75% | 71.00K 87.60% | 96.31K 35.64% | 56.22K 41.62% | 264.18K 369.90% | 258.71K 2.07% | 262.78K 1.57% | |
deferred income tax | -2.33M - | 266.11K - | 129.25K 51.43% | -237.54K 283.79% | -1.31M 451.47% | -479.26K 63.41% | -1.20M - | ||||
stock based compensation | 2.04M - | 2.19M 7.36% | 2.76M 26.18% | 2.71M 1.63% | 4.14M 52.67% | 8.08M 95.01% | 7.08M 12.36% | 7.11M 0.34% | 8.29M 16.61% | 5.75M 30.60% | |
change in working capital | 549.77K - | 536.83K 2.36% | 462.97K 13.76% | 215.45K 53.46% | 5.00M 2,220.01% | 2.74M 45.17% | -8.83M 422.14% | 7.44M 184.25% | -3.44M 146.30% | 861.18K 125.00% | |
accounts receivables | |||||||||||
inventory | |||||||||||
accounts payables | -559 - | 509.87K 91,310.38% | -575.72K 212.92% | 725.52K 226.02% | 2.05M 182.50% | -2.85M 238.86% | -426.66K 85.01% | 638.06K 249.55% | -886.08K 238.87% | 1.20M 235.93% | |
other working capital | 550.33K - | 26.96K 95.10% | 1.04M 3,752.86% | -510.07K 149.11% | 2.95M 678.13% | 5.59M 89.46% | -8.40M 250.40% | 6.80M 180.93% | -2.56M 137.62% | -343.25K 86.58% | |
other non cash items | 150.85K - | 35.83K 76.25% | 27.31K 23.77% | 20.34K 25.53% | 59.32K 191.64% | 6.23M 10,406.42% | 2.23M 64.24% | 409.47K 81.63% | 283.90K 30.67% | 1.54M 443.87% | |
net cash provided by operating activities | -4.78M - | -9.31M 94.97% | -15.15M 62.67% | -19.22M 26.90% | -29.86M 55.32% | -44.98M 50.66% | -37.49M 16.65% | -42.56M 13.50% | -56.64M 33.09% | -30.33M 46.46% | |
investments in property plant and equipment | -14.06K - | -86.12K 512.42% | -11.81K 86.29% | -24.76K 109.64% | -262.97K 962.10% | -9.53K 96.38% | -7.81K - | -16.32K 109.03% | |||
acquisitions net | 11.81K - | 24.76B 209,644,269.18% | 262.97B 962.10% | 609.46K 100.00% | 16.32K - | ||||||
purchases of investments | -12.95M - | -16.05M 23.92% | -35.10M 118.68% | -59.73M 70.20% | -57.77M 3.29% | -5.78M 90.00% | -92.94M - | ||||
sales maturities of investments | 15.84M - | 24.92M 57.39% | 36.66M 47.09% | 75.64M 106.35% | 34.80M 54.00% | 63M - | 30M 52.38% | ||||
other investing activites | -11.81K - | -24.76B 209,644,269.18% | -262.97B 962.10% | -16.32K - | |||||||
net cash used for investing activites | -14.06K - | -13.04M 92,605.56% | -225.23K 98.27% | -10.20M 4,427.67% | -23.34M 128.83% | 18.48M 179.18% | 29.02M 57.08% | -7.81K 100.03% | -29.95M 383,637.25% | 30M 200.15% | |
debt repayment | -1.40M - | -14.33M - | -1.04M - | ||||||||
common stock issued | 10.06M - | 28.51M 183.50% | 12.74M 55.31% | 37.59M 195.12% | 81.92M 117.91% | 7.89M 90.37% | 40.72M 415.94% | 189.81M 366.18% | 1.12M 99.41% | 305.23K 72.83% | |
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 1.40M - | -36.24K 102.60% | -165.93K - | -1.40M 741.22% | 30.01M 2,250.03% | 1.19M 96.05% | 4.68M 295.18% | 96.67K 97.94% | -532.95K 651.34% | ||
net cash used provided by financing activities | 10.06M - | 28.47M 183.14% | 12.74M 55.25% | 37.43M 193.82% | 80.53M 115.15% | 23.58M 70.72% | 41.90M 77.73% | 194.50M 364.17% | 1.22M 99.37% | -1.27M 204.11% | |
effect of forex changes on cash | |||||||||||
net change in cash | 5.26M - | 6.12M 16.27% | -2.63M 143.03% | 8.01M 404.06% | 27.33M 241.32% | -2.93M 110.73% | 33.43M 1,240.40% | 151.93M 354.45% | -85.37M 156.19% | -1.60M 98.13% | |
cash at beginning of period | 3.26M - | 8.53M 161.38% | 14.65M 71.79% | 12.02M 17.98% | 20.02M 66.65% | 47.36M 136.51% | 44.43M 6.19% | 77.86M 75.25% | 229.79M 195.14% | 144.42M 37.15% | |
cash at end of period | 8.53M - | 14.65M 71.79% | 12.02M 17.98% | 20.02M 66.65% | 47.36M 136.51% | 44.43M 6.19% | 77.86M 75.25% | 229.79M 195.14% | 144.42M 37.15% | 142.82M 1.11% | |
operating cash flow | -4.78M - | -9.31M 94.97% | -15.15M 62.67% | -19.22M 26.90% | -29.86M 55.32% | -44.98M 50.66% | -37.49M 16.65% | -42.56M 13.50% | -56.64M 33.09% | -30.33M 46.46% | |
capital expenditure | -14.06K - | -86.12K 512.42% | -11.81K 86.29% | -24.76K 109.64% | -262.97K 962.10% | -9.53K 96.38% | -7.81K - | -16.32K 109.03% | |||
free cash flow | -4.79M - | -9.40M 96.20% | -15.16M 61.31% | -19.25M 26.97% | -30.12M 56.49% | -44.99M 49.38% | -37.49M 16.67% | -42.56M 13.52% | -56.65M 33.10% | -30.33M 46.47% |
All numbers in USD (except ratios and percentages)